路易斯安那州试图封锁FDA的miferistone邮购规则, Louisiana seeks to block FDA’s mifepristone mail-order rule, citing safety and coercion concerns.

2026年2月24日, 路易斯安那州总检察长Liz Murrill在联邦法官面前争论, 试图阻止林业发展局的2023年规则允许邮购和远程医疗分配MIFEFEPristone, 声称这破坏了州近乎完全禁止堕胎的规定, Louisiana Attorney General Liz Murrill argued before a federal judge on February 24, 2026, seeking to block the FDA’s 2023 rule allowing mail-order and telehealth distribution of mifepristone, claiming it undermines the state’s near-total abortion ban and enables unsafe, coerced use. 她列举了不断上升的邮购堕胎和据称的胁迫行为,而林业发展局和药品制造商则维护这一规则,认为它是安全的,对获得服务至关重要。 She cited rising mail-order abortions and alleged coercion, while the FDA and drug manufacturers defended the rule as safe and essential for access. 该案作为更广泛的国家法律斗争的一部分,可以改变全国范围内获得堕胎药丸的情况。 The case, part of a broader national legal battle, could reshape abortion pill access nationwide.